{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:27:37Z","timestamp":1787984857176,"version":"build-2784847793"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.ajog.2017.03.021","type":"journal-article","created":{"date-parts":[[2017,5,10]],"date-time":"2017-05-10T03:00:19Z","timestamp":1494385219000},"page":"42-46.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Overview of high-risk medical device recalls in\u00a0obstetrics\u00a0and gynecology from 2002 through 2016:\u00a0implications for device safety"],"prefix":"10.1016","volume":"217","author":[{"given":"Timothy M.","family":"Janetos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Comeron W.","family":"Ghobadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2017.03.021_bib1","unstructured":"FDA. FDA public health notification: serious complications associated with transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence. Available at: http:\/\/www.fda.gov\/MedicalDevices\/Safety\/AlertsandNotices\/PublicHealthNotifications\/ucm061976.htm. Accessed August 6,\u00a02015."},{"key":"10.1016\/j.ajog.2017.03.021_bib2","unstructured":"FDA. FDA strengthens requirements for surgical mesh for the transvaginal repair of pelvic organ prolapse to address safety risks. Available at: http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm479732.htm. Accessed January 4,\u00a02016."},{"key":"10.1016\/j.ajog.2017.03.021_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju339","article-title":"FDA considers restricting or banning laparoscopic morcellation","volume":"106","author":"Brower","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ajog.2017.03.021_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ygyno.2016.11.002","article-title":"Morcellation worsens survival outcomes in patients with undiagnosed uterine leiomyosarcomas: a retrospective MITO group study","volume":"144","author":"Raspagliesi","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ajog.2017.03.021_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0000000000001157","article-title":"US Food and Drug Administration's guidance regarding morcellation of leiomyomas: well-intentioned, but is it harmful for women?","volume":"127","author":"Parker","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.03.021_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/AOG.0000000000001796","article-title":"Hysteroscopic sterilization with Essure: summary of the US Food and Drug Administration actions and policy implications for postmarketing surveillance","volume":"129","author":"Walter","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.03.021_bib7","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/AOG.0000000000001430","article-title":"Medical device approvals through the premarket approval pathway in obstetrics and gynecology from 2000 to 2015: process and problems","volume":"127","author":"Walter","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2017.03.021_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/1468-0009.12044","article-title":"Regulatory reticence and medical devices","volume":"92","author":"Fox","year":"2014","journal-title":"Milbank Q"},{"key":"10.1016\/j.ajog.2017.03.021_bib9","unstructured":"FDA. Classify your medical device. Available at: https:\/\/www.fda.gov\/MedicalDevices\/DeviceRegulationandGuidance\/Overview\/ClassifyYourDevice\/default.htm. Accessed July 29,\u00a02014."},{"key":"10.1016\/j.ajog.2017.03.021_bib10","unstructured":"FDA. Safety\u2013background and definitions. Available at: http:\/\/www.fda.gov\/Safety\/Recalls\/ucm165546.htm. Accessed June 24,\u00a02009."},{"key":"10.1016\/j.ajog.2017.03.021_bib11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jacr.2015.12.025","article-title":"Overview of class I device recalls in diagnostic radiology, 2002-2015","volume":"13","author":"Ghobadi","year":"2016","journal-title":"J\u00a0Am Coll Radiol"},{"key":"10.1016\/j.ajog.2017.03.021_bib12","unstructured":"FDA. Medical device recalls. Available at: http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfRES\/res.cfm. Accessed\u00a0December 31,\u00a02016."},{"key":"10.1016\/j.ajog.2017.03.021_bib13","unstructured":"FDA. Premarket notification 510(k). Available at: http:\/\/www.fda.gov\/medicaldevices\/deviceregulationandguidance\/howtomarketyourdevice\/premarketsubmissions\/premarketnotification510k\/default.htm. Accessed September 15,\u00a02016."},{"key":"10.1016\/j.ajog.2017.03.021_bib14","unstructured":"FDA. Recall\u2013firm press release. Available at: http:\/\/www.fda.gov\/Safety\/Recalls\/ucm411442.htm. Accessed August 27,\u00a02014."},{"key":"10.1016\/j.ajog.2017.03.021_bib15","doi-asserted-by":"crossref","first-page":"e1001276","DOI":"10.1371\/journal.pmed.1001276","article-title":"How does medical device regulation perform in the United States and the European Union? A systematic review","volume":"9","author":"Kramer","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajog.2017.03.021_bib16","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archinternmed.2011.30","article-title":"Medical device recalls and the FDA approval process","volume":"171","author":"Zuckerman","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajog.2017.03.021_bib17","unstructured":"Institute of Medicine. Medical devices and the public\u2019s health: the FDA 510(k) clearance process at 35 years. 2011. Available at: http:\/\/www.nationalacademies.org\/hmd\/Reports\/2011\/Medical-Devices-and-the-Publics-Health-The-FDA-510k-Clearance-Process-at-35-Years.aspx. Accessed June 1, 2016."},{"key":"10.1016\/j.ajog.2017.03.021_bib18","unstructured":"US Government Accountability Office. FDA should take steps to ensure that high-risk device types are approved through the most stringent premarket review process. Available at: http:\/\/www.gao.gov\/assets\/290\/284882.pdf. Accessed\u00a0December 15, 2016."},{"key":"10.1016\/j.ajog.2017.03.021_bib19","unstructured":"Hall R. A critical balance: FDA and the reform of the medical device approval process, US Senate HELP Committee. Available at: http:\/\/www.help.senate.gov\/imo\/media\/doc\/Hall.pdf. Accessed\u00a0October 1, 2016."},{"key":"10.1016\/j.ajog.2017.03.021_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jacr.2016.08.014","article-title":"Radiological innovation: device approvals via the pre-market approval pathway from 2000 to 2015","volume":"14","author":"Ghobadi","year":"2017","journal-title":"J\u00a0Am Coll Radiol"},{"key":"10.1016\/j.ajog.2017.03.021_bib21","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s10620-016-4117-2","article-title":"Overview of high-risk medical device innovation in gastroenterology from 2000 to 2014: enhancing the pipeline","volume":"61","author":"Saleem","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ajog.2017.03.021_bib22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCOUTCOMES.114.001460","article-title":"Medical device postapproval safety monitoring: where does the United States stand?","volume":"8","author":"Rajan","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ajog.2017.03.021_bib23","unstructured":"FDA. Current postmarket surveillance efforts. Available at: http:\/\/www.fda.gov\/MedicalDevices\/Safety\/CDRHPostmarketSurveillance\/ucm348738.htm. Accessed June 5,\u00a02014."},{"key":"10.1016\/j.ajog.2017.03.021_bib24","doi-asserted-by":"crossref","unstructured":"Mukherjee UK, Sinha KK. Product recall decisions in medical device supply chains: a big data analytic approach to evaluating judgment bias. Production and Operations Management 2017. Available at: http:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/poms.12696\/full. Accessed April 27, 2017.","DOI":"10.1111\/poms.12696"},{"key":"10.1016\/j.ajog.2017.03.021_bib25","unstructured":"FDA. FDA issues proposals to address risks associated with surgical\u00a0mesh for transvaginal repair of pelvic organ prolapse. Available at: https:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm395192.htm. Accessed April 29,\u00a02014."},{"key":"10.1016\/j.ajog.2017.03.021_bib26","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/jama.2016.8708","article-title":"Need for a national evaluation system for health technology","volume":"316","author":"Shuren","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2017.03.021_bib27","unstructured":"114th Congress of the United States. 21 st Century Cures Act, H.R. 34. Available at: http:\/\/docs.house.gov\/billsthisweek\/20161128\/CPRT-114-HPRT-RU00-SAHR34.pdf. Accessed December 15, 2016."},{"key":"10.1016\/j.ajog.2017.03.021_bib28","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMp1506964","article-title":"The 21st Century Cures Act\u2013will it take us back in time?","volume":"372","author":"Avorn","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2017.03.021_bib29","unstructured":"FDA. Strategic priorities. Available at: http:\/\/www.fda.gov\/downloads\/AboutFDA\/CentersOffices\/OfficeofMedicalProductsandTobacco\/CDRH\/CDRHVisionandMission\/UCM481588.pdf. Accessed December 15, 2016."},{"key":"10.1016\/j.ajog.2017.03.021_bib30","unstructured":"FDA. Quality system (QS) regulation\/medical device Good Manufacturing Practices. Available at: https:\/\/www.fda.gov\/medicaldevices\/deviceregulationandguidance\/postmarketrequirements\/qualitysystemsregulations\/default.htm. Accessed July 29,\u00a02016."},{"key":"10.1016\/j.ajog.2017.03.021_bib31","unstructured":"US Government Accountability Office. Challenges for FDA in conducting manufacturer inspections. Available at: http:\/\/www.gao.gov\/assets\/120\/118799.pdf. Accessed\u00a0March 10, 2017."},{"key":"10.1016\/j.ajog.2017.03.021_bib32","unstructured":"FDA. Medical Device Single Audit Program (MDSAP) pilot. Available at: http:\/\/www.fda.gov\/MedicalDevices\/InternationalPrograms\/MDSAPPilot\/. Accessed December 16,\u00a02016."}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817304593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937817304593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:15:05Z","timestamp":1757589305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937817304593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0002937817304593"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2017.03.021","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overview of high-risk medical device recalls in\u00a0obstetrics\u00a0and gynecology from 2002 through 2016:\u00a0implications for device safety","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2017.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}